Structure |
Chemical Name |
CAS |
MF |
|
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
|
Lesinurad Impurity |
|
|
|
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
|
Cefminox sodium impurities Ⅲ |
|
|
|
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
|
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
|
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
|
Moxifloxacin EP Impurity A HCl |
|
|
|
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
|
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
|
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
|
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
|
N-エチル-N-メチルカルバモイルクロリド |
42252-34-6 |
C4H8ClNO |
|
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
|
(3S)-N-[(1R)-1-フェニルエチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン二塩酸塩 |
128311-06-8 |
C15H24Cl2N2 |
|
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
|
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
|
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
|
Trelagliptin Impurity 16 |
|
|
|
Decitabine Impurity 7 |
|
|
|
Fosaprepitant Impurity 6 |
|
|
|
Dapoxetine Impurity 6 |
|
|
|
Regorafenib Impurity 13 |
|
|
|
Topiroxostat Impurity 4 |
|
|
|
Bosutinib Impurity 8 |
|
|
|
Ticagrelor Impurity 13 |
|
|
|
Ticagrelor Impurity 66 |
|
|
|
Canagliflozin Impurity 8 |
|
|
|
Canagliflozin Impurity 16 |
|
|
|
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
|
1,1-ジフェニル-1-プロパノール |
5180-33-6 |
C15H16O |
|
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
|
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
|
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
|
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
|
Ceftazidime Impurity D |
|
|
|
Ceftazidime Sulfoxide Impurity |
|
|
|
Tofacitinib Impurity Y |
|
|
|
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
|
Landiolol impurity K |
190601-22-0 |
C19H29N3O6 |
|
Crisaborole Impurity |
906673-42-5 |
C14H10BNO3 |
|
Olanzapine impurity N |
|
C17H20N4S |
|
Cabozantinib impurity 25 |
|
|
|
Vildagliptin Impurity 39 |
|
|
|
Tazobactam Impurity D |
|
|
|
Palonosetron Impurity 22 |
1217547-14-2 |
C19H24N2O2 |
|
Pitavastatin Impurity 35 |
|
|
|
Pralatrexate Impurity 15 |
|
|
|
Pitavastatin Impurity 52 |
|
|
|
Pitavastatin Impurity 60 |
1661064-71-6 |
C25H22FNO3 |
|
Lenvatinib Impurity 43 |
|
|
|
Voriconazole Impurity 10 |
|
|
|
Prednicarbate Impurity D |
|
|
|
Olprinone Impurity A |
141354-29-2 |
C12H10N4O |
|
Oseltamivir Impurity 12 |
|
|
|
Oseltamivir Impurity 32 |
|
|
|
Riociguat IMpurtiy E |
|
|
|
Meropenem impurity diastereomer 2 |
96035-15-3 |
C15H19N3O5S |
|
Clindamycin Impurity A |
|
|
|
Tigecycline Impurity F |
|
|
|
Fasudil iMpurity A |
|
|
|
Cefminox Impurity C |
|
|
|
4,5-ジブロモピロカテコール |
2563-26-0 |
C6H4Br2O2 |
|
クロピドグレル関連化合物A |
144457-28-3 |
C15H14ClNO2S |
|
RAC-(CIS/TRANS) ドネペジルN-オキシド |
120013-84-5 |
C24H29NO4 |
|
5-カルボキシ-2'-デオキシウリジン |
14599-46-3 |
C10H12N2O7 |
|
2-Desisopropyl-2-phenyl Repaglinide |
107362-12-9 |
C30H34N2O4 |
|
2-(3-CHLOROPHENYL)-2-CYANO-1-(3-PYRIDINYL)-1-ETHANONE |
114444-10-9 |
C14H9ClN2O |
|
Brivaracetam Impurity 37 |
|
|
|
Ticagrelor Impurity 133 |
|
|
|
4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide |
1187188-59-5 |
C14H12BNO4 |
|
2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]- |
219915-41-0 |
C10H10O3 |
|
L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]- |
61475-35-2 |
C5H9NO5S |
|
アゾベンゼン-2-オール |
2362-57-4 |
C12H10N2O |
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
|
Hexanoic acid, 3-(hydroxymethyl)- |
81381-87-5 |
C7H14O3 |
|
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
|
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)- |
946525-39-9 |
C22H27ClO6 |
|
Topiroxostat Impurity 42 |
|
|
|
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
|
Regorafenib Impurity MHY |
|
|
|
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
|
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
|
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
|
Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- |
2247538-61-8 |
C23H30FN3O2 |
|
Vonoprazan Impurity B-3 |
|
|
|
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-51-2 |
C16H19N7O3S |
|
Budesonide Impurity 26 |
|
|
|
Peramivir Impurity 48 |
|
|
|
Tolvaptan dehydroxylated impurity |
|
|
|
3-Quinolinemethanol, 2-cyclopropyl-4-phenyl- |
2153433-73-7 |
C19H17NO |
|
Piperacillin ImpurityABCDEFGHI |
|
|
|
5,6-ジメトキシ-2-(4-ピリジルメチル)-1-インダノン |
4803-57-0 |
C17H17NO3 |
|
3-(ジメチルアミノ)-1-(2-チエニル)-1-プロパノール |
13636-02-7 |
C9H15NOS |
|
Benzamide, 2,5-dichloro-N-(3-methylbutyl)- |
349086-08-4 |
C12H15Cl2NO |
|
3-[(4-アミノ-2-メチル-5-ピリミジニル)メチル]-5-(2-クロロエチル)-4-メチルチアゾール-3-イウム·クロリド |
13471-78-8 |
C12H16Cl2N4S |
|
2-メトキシ-5-スルホ安息香酸1-メチル |
94134-07-3 |
C9H10O6S |
|
2,4-ジオキソ-3-アザスピロ[5.5]ウンデカン-1,5-ジカルボニトリル |
4355-15-1 |
C12H13N3O2 |
|
INDEX NAME NOT YET ASSIGNED |
2412953-11-6 |
C72H112O49S8 |
|
Sulfamide, N-[5-phenyl-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N'-propyl- |
2300968-85-6 |
C19H22N6O4S |